Plymouth Buys iSOFT Business Intelligence to Raise Labs Performance

iSOFTiSOFT, a CSC company, has agreed a deal with Plymouth Hospitals NHS Trust for a business intelligence tool to boost performance across its busy laboratory departments to deliver continuous service improvements.

Drawing information from the iSOFT laboratory system at Plymouth, the new solution will provide a dashboard to monitor key performance indicators in real time. This includes the turnaround times of test samples to guarantee targets are met. The trust faces local and national NHS targets for A&E specimens for instance, plus contractual targets for commercial treatment centres and private healthcare firms.

"The iSOFT solution will allow us to proactively manage specimens to identify potential breaches in turnaround times before they become critical," said Adrian Heathcote, the trust's pathology IT manager. "This represents a fundamental shift in ethos.

"It is impossible to monitor targets in real time using the data extract tools commonly found in pathology departments, so breaches only become apparent after the event," he added. "The solution will help mitigate risk and is an additional tool to help us continue with our other customer-focused service improvements."

A second phase will see iSOFT's laboratory business intelligence solution used to optimise workflows and improve performance. This includes plans to examine demand to ensure the right people and skills are in place at peak times and to pinpoint bottlenecks.

The solution will used across all three laboratories at Plymouth's Derriford Hospital and across all laboratory disciplines, including histopathology, microbiology, haematology, and clinical biochemistry. The trust's Pathology Directorate employs 257 staff and conducts 6.5 million tests on 1.3 million specimens a year.

"Seventy to eighty percent of diagnoses now rely on pathology tests and the pressure on laboratory services will only intensify," said Adrian Stevens, managing director of iSOFT's UK business. "Our solution gives pathology departments the means to remove inefficiencies and find savings.

"As an early adopter, we will work closely with Plymouth to further shape the product to meet specific NHS needs."

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...